We are live on ! Find out more
PGEN icon

Precigen

100 hedge funds and large institutions have $2.2B invested in Precigen in 2014 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 37 increasing their positions, 24 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 11

54% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 24

28% more funds holding

Funds holding: 78100 (+22)

26% more call options, than puts

Call options by funds: $8.38M | Put options by funds: $6.64M

17% more capital invested

Capital invested by funds: $1.88B → $2.2B (+$321M)

4.45% more ownership

Funds ownership: 85.32%89.76% (+4.4%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
100
Holders Change
+22
Holders Change %
+28.21%
% of All Funds
2.88%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
33
Increased
37
Reduced
24
Closed
11
Calls
$8.38M
Puts
$6.64M
Net Calls
+$1.74M
Net Calls Change
+$1.61M

PGEN Hedge Fund Activity: Q1 2014 in Review

100 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q1 2014, worth a combined $2.2B — up 17% from $1.88B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new PGEN positions and 11 closed out — a net gain of 22 holders — while 37 added to existing stakes and 24 trimmed.

The largest buyer was Vanguard Group, adding an estimated $48.1M. The largest seller was Greenlight Capital, cutting an estimated $24M.

  • 100 institutional investors held Precigen (PGEN) as of Q1 2014, up from 78 in Q4 2013.
  • Funds reported $2.2B of Precigen stock for Q1 2014, up 17% quarter-over-quarter.
  • 33 funds opened new Precigen positions in Q1 2014 and 11 closed out, a net change of +22 holders.
  • The largest Precigen buyer in Q1 2014 was Vanguard Group, an estimated $48.1M added.
  • The largest Precigen seller in Q1 2014 was Greenlight Capital, an estimated $24M sold.

Based on aggregated 13F filings for Q1 2014.